Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: 5-HT₃ Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Transducer Mechanism: Nuclear Receptors

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

Drug-Receptor Interaction: Antagonist

Drug-Receptor Interaction: Antagonist

An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Drug-Receptor Interaction: Agonist

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Post-ERCP Outcomes in Cirrhotic Patients With Thrombocytopenia: A Propensity-Matched Retrospective Comparative Analysis on TriNetX Health Research Database.

JGH open : an open access journal of gastroenterology and hepatology·2026

Same author

HIV and Hickam's Dictum: Multiple Opportunistic Infections.

ACG case reports journal·2026

Same author

IMPACT OF FLUORESCENT DYES ON MUTATIONS IN NEXT GENERATION SEQUENCING LIRBARY PREPARATION.

bioRxiv : the preprint server for biology·2026

Same author

Association of Preoperative Potassium Levels with 30-Day Mortality and Other Postoperative Outcomes in Noncardiac Surgery at a Tertiary Care Center: A Retrospective Study.

Nephron·2026

Same author

Diagnostic accuracy and safety of Cy-Tb for detection of tuberculosis infection: A multicentric study from India.

The Indian journal of medical research·2026

Same author

A Systematic Review of Ipilimumab-Induced Hypophysitis.

Endocrine connections·2026

Search research articles

Related Experiment Video

Updated: May 12, 2026

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids

Published on: June 28, 2019

5-Oxo-ETE receptor antagonists.

Vivek Gore¹, Pranav Patel, Chih-Tsung Chang

¹Claude Pepper Institute and Department of Chemistry, Florida Institute of Technology, 150 West University Boulevard, Melbourne, Florida 32901, United States.

Journal of Medicinal Chemistry

|April 16, 2013

Summary

Researchers developed a novel drug to block 5-oxo-ETE, a key molecule driving eosinophil buildup in asthma. This new 5-oxo-ETE receptor antagonist aims to prevent lung inflammation and ease asthma symptoms.

Related Experiment Videos

Last Updated: May 12, 2026

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids

Published on: June 28, 2019

Area of Science:

Biochemistry
Immunology
Pharmacology

Background:

5-Oxo-ETE is a potent lipid mediator that attracts eosinophils.
Eosinophil infiltration in the lungs contributes to the late phase of inflammatory asthma.

Purpose of the Study:

To design and synthesize a novel 5-oxo-ETE receptor antagonist.
To investigate the potential of this antagonist in preventing eosinophil migration to the lungs during asthma attacks.

Main Methods:

Chemical synthesis of the 5-oxo-ETE receptor antagonist.
In vitro and/or in vivo studies to assess the antagonist's efficacy in blocking eosinophil migration (details not provided in abstract).

Main Results:

Successful design and synthesis of a 5-oxo-ETE receptor antagonist.
The antagonist is designed to inhibit eosinophil migration (specific results not provided in abstract).

Conclusions:

The developed 5-oxo-ETE receptor antagonist shows promise for managing asthma.
This therapeutic strategy may reduce asthma symptoms by preventing eosinophil-driven lung inflammation.